Poly Medicure Financial Statements

Poly Medicure (POLYMED) reported revenue of ₹17.59B in FY2025 with net income of ₹3.39B. Total assets stood at ₹31.92B and free cash flow was -₹906.06M.

Poly Medicure Income Statement

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025

Item	Chart	2021	2022	2023	2024	2025
Revenue		7.86B	9.61B	11.51B	14.35B	17.59B
Cost of Rev. Cost of Revenue		-2.62B	-3.48B	-4.06B	-4.83B	-5.55B
Gross Profit		5.25B	6.13B	7.46B	9.52B	12.04B
SGA Sales, General & Admin		-3.10B	-3.62B	-4.44B	-5.35B	-6.62B
Op. Income Operating Income		1.67B	1.97B	2.44B	3.53B	4.59B
PBT Profit Before Tax		1.77B	1.95B	2.37B	3.44B	4.53B
Net Income		1.36B	1.47B	1.79B	2.58B	3.39B
Dil. Shares Diluted Shares		89.16M	95.96M	96.02M	96.02M	99.24M
Diluted EPS		15.24	15.27	18.67	26.90	34.11

Figures in ₹ — millions (M), billions (B), trillions (T). EPS is earnings per share.

Understanding the Income Statement

The income statement shows Poly Medicure's revenue and expenses over a period. Revenue minus costs gives gross profit; after operating expenses, interest, and taxes, the remainder is net income. Diluted EPS divides net income by all shares that could exist if options and convertibles were exercised.

Poly Medicure Balance Sheet

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025

Item	Chart	2021	2022	2023	2024	2025
Curr. assets Total current assets		7.06B	7.83B	8.07B	8.42B	19.17B
Non-curr. assets Total non-current assets		5.18B	5.93B	7.71B	10.17B	12.75B
Total assets		12.24B	13.77B	15.77B	18.59B	31.92B
Curr. liabilities Total current liabilities		1.71B	2.27B	2.93B	3.51B	3.70B
Non-curr. liab. Total non-current liabilities		867.63M	626.75M	422.79M	374.04M	566.25M
Total liabilities		2.58B	2.89B	3.36B	3.89B	4.27B
Total equity		9.66B	10.87B	12.42B	14.70B	27.66B
Total liab. & eq. Total liabilities & equity		12.24B	13.77B	15.77B	18.59B	31.92B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding the Balance Sheet

The balance sheet captures Poly Medicure's financial position at a point in time — what it owns (assets), what it owes (liabilities), and the residual value to shareholders (equity). Total assets always equals total liabilities plus equity.

Poly Medicure Cash Flow Statement

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025

Item	Chart	2021	2022	2023	2024	2025
Net Income		1.80B	1.95B	2.37B	3.44B	4.53B
Operating CF Cash flow Operating Activities		1.19B	1.23B	1.91B	2.66B	2.40B
Capex Investments in PPE		-951.31M	-1.56B	-2.39B	-2.77B	-3.31B
Investing CF Cash flow Investing Activities		-4.36B	-853.32M	-1.79B	-2.41B	-11.94B
Dividend Paid		0	-239.16M	-239.73M	-287.40M	-303.41M
Financing CF Cash flow Financing Activities		3.17B	-353.38M	-125.05M	-201.54M	9.51B
Cash (start) Cash at beginning of period		48.57M	49.55M	77.57M	70.62M	120.53M
Cash (end) Cash at end of period		49.55M	77.57M	70.62M	120.53M	86.99M
FCF Free Cash Flow		236.01M	-321.06M	-484.49M	-109.34M	-906.06M

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding Cash Flow

The cash flow statement tracks how Poly Medicure's cash moves through operations, investing, and financing activities. Free cash flow — operating cash minus capital expenditure — shows what is available to return to shareholders.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025